These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

885 related items for PubMed ID: 16336449

  • 1. Impact of Helicobacter pylori eradication on the anti-secretory efficacy of lansoprazole in gastroesophageal reflux disease patients.
    Giral A, Celikel CA, Ozdogan O, Tözün N, Ulusoy NB, Kalayci C.
    J Gastroenterol Hepatol; 2005 Dec; 20(12):1886-91. PubMed ID: 16336449
    [Abstract] [Full Text] [Related]

  • 2. Quantitative assessment of gastric corpus atrophy in subjects using omeprazole: a randomized follow-up study.
    van Grieken NC, Meijer GA, Weiss MM, Bloemena E, Lindeman J, Baak JP, Meuwissen SG, Kuipers EJ.
    Am J Gastroenterol; 2001 Oct; 96(10):2882-6. PubMed ID: 11693321
    [Abstract] [Full Text] [Related]

  • 3. Helicobacter pylori and the efficacy of omeprazole therapy for gastroesophageal reflux disease.
    Schenk BE, Kuipers EJ, Klinkenberg-Knol EC, Eskes SA, Meuwissen SG.
    Am J Gastroenterol; 1999 Apr; 94(4):884-7. PubMed ID: 10201451
    [Abstract] [Full Text] [Related]

  • 4. Effect of four lansoprazole dose levels and one dosage regimen of omeprazole on 24-hour intragastric pH in healthy subjects.
    Timmer W, Ripke H, Kleist P, Ehrlich A, Wieckhorst G, Lücker PW, Fuder H.
    Methods Find Exp Clin Pharmacol; 1995 Sep; 17(7):489-95. PubMed ID: 8577212
    [Abstract] [Full Text] [Related]

  • 5. Is Helicobacter pylori eradication associated with gastroesophageal reflux disease?
    Fallone CA, Barkun AN, Friedman G, Mayrand S, Loo V, Beech R, Best L, Joseph L.
    Am J Gastroenterol; 2000 Apr; 95(4):914-20. PubMed ID: 10763937
    [Abstract] [Full Text] [Related]

  • 6. Stability of gastric secretory inhibition during 6-month treatment with omeprazole in patients with gastroesophageal reflux disease.
    Tefera S, Hatlebakk JG, Berstad A.
    Am J Gastroenterol; 2001 Apr; 96(4):969-74. PubMed ID: 11316213
    [Abstract] [Full Text] [Related]

  • 7. Effect of frequent dosing of an oral proton pump inhibitor on intragastric pH.
    Pais SA, Nathwani RA, Dhar V, Nowain A, Laine L.
    Aliment Pharmacol Ther; 2006 Jun 01; 23(11):1607-13. PubMed ID: 16696810
    [Abstract] [Full Text] [Related]

  • 8. Usefulness of proton pump inhibitor (PPI) maintenance therapy for patients with H. pylori-negative recurrent peptic ulcer after eradication therapy for H. pylori: pathophysiological characteristics of H. pylori-negative recurrent ulcer scars and beyond acid suppression by PPI.
    Ohara T, Morishita T, Suzuki H, Masaoka T, Ishii H.
    Hepatogastroenterology; 2004 Jun 01; 51(56):338-42. PubMed ID: 15086153
    [Abstract] [Full Text] [Related]

  • 9. Eradication therapy of Helicobacter pylori directly induces apoptosis in inflammation-related immunocytes in the gastric mucosa--possible mechanism for cure of peptic ulcer disease and MALT lymphoma with a low-grade malignancy.
    Ohara T, Kanoh Y, Higuchi K, Arakawa T, Morisita T.
    Hepatogastroenterology; 2003 Jun 01; 50(51):607-9. PubMed ID: 12828043
    [Abstract] [Full Text] [Related]

  • 10. Lansoprazole: a comprehensive review.
    Zimmermann AE, Katona BG.
    Pharmacotherapy; 1997 Jun 01; 17(2):308-26. PubMed ID: 9085323
    [Abstract] [Full Text] [Related]

  • 11. [Does H. pylori infection or its eradication play a role in gastroeosphageal reflux disease?].
    Zerbib F.
    Gastroenterol Clin Biol; 2003 Mar 01; 27(3 Pt 2):427-31. PubMed ID: 12700499
    [Abstract] [Full Text] [Related]

  • 12. [Long-term course of reflux symptoms following Helicobacter pylori eradication].
    Peitz U, Raps S, Plein K, Leodolter A, Hotz Dagger J, Malfertheiner P.
    Dtsch Med Wochenschr; 2004 Mar 26; 129(13):671-5. PubMed ID: 15026962
    [Abstract] [Full Text] [Related]

  • 13. Helicobacter pylori and gastroesophageal reflux disease: friends or foes?
    Gisbert JP, Pajares JM, Losa C.
    Hepatogastroenterology; 1999 Mar 26; 46(26):1023-9. PubMed ID: 10370661
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of omeprazole one year after cure of Helicobacter pylori infection in duodenal ulcer patients.
    Labenz J, Tillenburg B, Peitz U, Börsch G, Idström JP, Verdú E, Stolte M, Blum AL.
    Am J Gastroenterol; 1997 Apr 26; 92(4):576-81. PubMed ID: 9128302
    [Abstract] [Full Text] [Related]

  • 15. Symptomatic benefit 1-3 years after H. pylori eradication in ulcer patients: impact of gastroesophageal reflux disease.
    McColl KE, Dickson A, El-Nujumi A, El-Omar E, Kelman A.
    Am J Gastroenterol; 2000 Jan 26; 95(1):101-5. PubMed ID: 10638566
    [Abstract] [Full Text] [Related]

  • 16. Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use.
    Lai KC, Lam SK, Chu KM, Wong BC, Hui WM, Hu WH, Lau GK, Wong WM, Yuen MF, Chan AO, Lai CL, Wong J.
    N Engl J Med; 2002 Jun 27; 346(26):2033-8. PubMed ID: 12087138
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of treatment for gastro-oesophageal reflux disease with a proton pump inhibitor, and relationship between gastro-oesophageal reflux disease and Helicobacter pylori infection in Japan.
    Muramatsu A, Azuma T, Okajima T, Ohtani M, Dojo M, Yamazaki Y, Kuriyama M.
    Aliment Pharmacol Ther; 2004 Jul 27; 20 Suppl 1():102-6. PubMed ID: 15298614
    [Abstract] [Full Text] [Related]

  • 18. Helicobacter pylori infection influences symptomatic response to anti-secretory therapy in patients with GORD--crossover comparative study with famotidine and low-dose lansoprazole.
    Adachi K, Hashimoto T, Komazawa Y, Mihara T, Furuta K, Fujishiro H, Ishihara S, Amano Y, Hattori S, Kinoshita Y.
    Dig Liver Dis; 2005 Jul 27; 37(7):485-90. PubMed ID: 15975534
    [Abstract] [Full Text] [Related]

  • 19. Should Helicobacter pylori be eradicated before starting long-term proton pump inhibitors?
    Rauws EA.
    Ital J Gastroenterol Hepatol; 1997 Dec 27; 29(6):569-73. PubMed ID: 9513835
    [Abstract] [Full Text] [Related]

  • 20. Progress with proton pump inhibitors in acid peptic disease: treatment of duodenal and gastric ulcer.
    Florent C.
    Clin Ther; 1993 Dec 27; 15 Suppl B():14-21. PubMed ID: 7911399
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 45.